IL246172D0
Optimized pharmaceutical formulation for the treatment of inflammatory conditions of the esophagus
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
63 members in 25 offices
Priority claims6
| Document | Office | Kind | Date |
|---|---|---|---|
| 13199278 | European Patent Office (EPO) | A | |
| 2014078391 | European Patent Office (EPO) | W | |
| 131992786 | – | – | – |
| EP20130199278 | – | – | – |
| PCTEP2014078391 | – | – | – |
| WO2014EP78391 | – | – | – |
Members63
| Document | Office | Kind | |
|---|---|---|---|
| EP2886108A1 | European Patent Office (EPO) | A1 | |
| CA2934009A1 | Canada | A1 | |
| WO2015097053A1 | World Intellectual Property Organization (WIPO) | A1 | |
| HK1209362A1 | Hong Kong, China | A1 | |
| AU2014372739A1 | Australia | A1 | |
| IL246172D0This record | Israel | D0 | |
| CN105848648A | China | A | |
| EP3086782A1 | European Patent Office (EPO) | A1 | |
| US2016324772A1 | United States of America | A1 | |
| JP2017500361A | Japan | A | |
| EA201600497A1 | Eurasian Patent Organization (EAPO) | A1 | |
| ZA201604225B | South Africa | B | |
| US9867780B2 | United States of America | B2 | |
| EA029166B1 | Eurasian Patent Organization (EAPO) | B1 | |
| UA117162C2 | Ukraine | C2 | |
| US2018185277A1 | United States of America | A1 | |
| EP3086782B1 | European Patent Office (EPO) | B1 | |
| PT3086782T | Portugal | T | |
| TR201815823T4 | Türkiye | T4 | |
| DK3086782T3 | Denmark | T3 | |
| LT3086782T | Lithuania | T | |
| SI3086782T1 | Slovenia | T1 | |
| ES2694331T3 | Spain | T3 | |
| HRP20181799T1 | Croatia | T1 | |
| IL246172A | Israel | A | |
| IL246172B | Israel | B | |
| EP2886108B1 | European Patent Office (EPO) | B1 | |
| RS58112B1 | Serbia | B1 | |
| LT2886108T | Lithuania | T | |
| PL3086782T3 | Poland | T3 | |
| DK2886108T3 | Denmark | T3 | |
| PT2886108T | Portugal | T | |
| RS58543B1 | Serbia | B1 | |
| JP6522626B2 | Japan | B2 | |
| HRP20190677T1 | Croatia | T1 | |
| SI2886108T1 | Slovenia | T1 | |
| AU2014372739B2 | Australia | B2 | |
| ES2716990T3 | Spain | T3 | |
| HUE041911T2 | Hungary | T2 | |
| HUE042009T2 | Hungary | T2 | |
| CN105848648B | China | B | |
| US10369100B2 | United States of America | B2 | |
| JP2019142931A | Japan | A | |
| PL2886108T3 | Poland | T3 | |
| US2019358155A1 | United States of America | A1 | |
| CA2934009C | Canada | C | |
| CY1121168T1 | Cyprus | T1 | |
| CY1121523T1 | Cyprus | T1 | |
| US10695291B2 | United States of America | B2 | |
| JP6757444B2 | Japan | B2 | |
| US2020337997A1 | United States of America | A1 | |
| JP2020196753A | Japan | A | |
| NZ721495A | New Zealand | A | |
| JP7009575B2 | Japan | B2 | |
| US11382860B2 | United States of America | B2 | |
| EP2886108B2 | European Patent Office (EPO) | B2 | |
| DK2886108T4 | Denmark | T4 | |
| HRP20190677T4 | Croatia | T4 | |
| FI2886108T4 | Finland | T4 | |
| PL2886108T5 | Poland | T5 | |
| RS58543B2 | Serbia | B2 | |
| SI2886108T2 | Slovenia | T2 | |
| ES2716990T5 | Spain | T5 |
3 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Patent renewedKB | KB | |
| Patent renewedKB | KB | |
| Patent grantedGrantedFF | FF |
Numbers
- Publication
- 246172
- Publication, DOCDB
- 246172
- Publication, EPODOC
- IL246172D
- Application
- 246172
- Application, DOCDB
- 24617216
- Application, EPODOC
- IL20160246172
Titles2
- English
- Optimized pharmaceutical formulation for the treatment of inflammatory conditions of the esophagus
- Hebrew
- תכשיר רוקחי מותאם לטיפול במצבים דלקתיים של הושט
Classification
- CPC, 7
- A61K31/58
- A61K9/0056
- A61K9/0007
- A61P1/00
- A61P1/04
- A61P29/00
- A61K9/2013
- IPC, 1
- A61K